Total Payments
$7,233
2024 Payments
$1,493
Companies
37
Transactions
352
Medicare Patients
6,399
Medicare Billing
$687,336
Payment Breakdown by Category
Food & Beverage$5,733 (79.3%)
Consulting$1,200 (16.6%)
Education$300.66 (4.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,733 | 344 | 79.3% |
| Consulting Fee | $1,200 | 1 | 16.6% |
| Education | $300.66 | 7 | 4.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,300 | 39 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $1,210 | 2 | $0 (2021) |
| PFIZER INC. | $1,003 | 76 | $0 (2024) |
| ABBVIE INC. | $471.66 | 28 | $0 (2024) |
| Novo Nordisk Inc | $414.41 | 34 | $0 (2024) |
| Astellas Pharma US Inc | $383.56 | 13 | $0 (2023) |
| GlaxoSmithKline, LLC. | $308.71 | 22 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $206.04 | 21 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $174.42 | 13 | $0 (2024) |
| Amarin Pharma Inc. | $169.77 | 10 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,493 | 42 | AstraZeneca Pharmaceuticals LP ($712.55) |
| 2023 | $587.73 | 31 | AstraZeneca Pharmaceuticals LP ($183.22) |
| 2022 | $511.71 | 30 | AstraZeneca Pharmaceuticals LP ($124.99) |
| 2021 | $1,636 | 26 | Biohaven Pharmaceuticals, Inc. ($1,210) |
| 2020 | $331.36 | 22 | PFIZER INC. ($160.49) |
| 2019 | $1,021 | 77 | PFIZER INC. ($328.84) |
| 2018 | $864.04 | 76 | Takeda Pharmaceuticals U.S.A., Inc. ($166.90) |
| 2017 | $789.40 | 48 | PFIZER INC. ($191.66) |
All Payment Transactions
352 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2024 | Hologic Sales and Service, LLC | CoolSeal Generator (Device) | Food and Beverage | In-kind items and services | $90.90 | General |
| Category: Surgical | ||||||
| 12/14/2024 | Davol Inc. | Phasix Mesh (Device) | Food and Beverage | In-kind items and services | $40.00 | General |
| Category: Surgery | ||||||
| 12/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $119.41 | General |
| Category: PAIN | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Obesity | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Respiratory | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: Respiratory | ||||||
| 09/26/2024 | Acella Pharmaceuticals, LLC | NP Thyroid 60 (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Hyperthyroidism | ||||||
| 09/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Diabetes Care | ||||||
| 09/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.18 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.36 | General |
| Category: PSYCHIATRY | ||||||
| 07/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: RESPIRATORY | ||||||
| 07/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: Oncology | ||||||
| 07/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/27/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $121.81 | General |
| Category: Cardiovascular | ||||||
| 06/20/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $93.47 | General |
| Category: Respiratory | ||||||
| 06/18/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 06/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,976 | 2,673 | $409,607 | $231,498 |
| 2022 | 16 | 1,758 | 2,309 | $311,615 | $187,582 |
| 2021 | 18 | 1,587 | 1,952 | $265,316 | $161,841 |
| 2020 | 16 | 1,078 | 1,483 | $188,284 | $106,416 |
Total Patients
6,399
Total Services
8,417
Medicare Billing
$687,336
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 402 | 887 | $169,863 | $87,659 | 51.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 340 | 340 | $62,119 | $46,738 | 75.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 361 | 362 | $54,300 | $31,467 | 58.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 205 | 392 | $51,514 | $26,634 | 51.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 338 | 338 | $14,340 | $6,892 | 48.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 72 | 89 | $14,567 | $6,207 | 42.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 27 | 27 | $6,360 | $4,844 | 76.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 27 | 27 | $6,485 | $4,832 | 74.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 22 | 24 | $8,440 | $4,251 | 50.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 14 | $6,356 | $3,377 | 53.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 40 | 40 | $3,280 | $3,032 | 92.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 13 | $3,242 | $2,018 | 62.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 45 | 45 | $2,025 | $1,479 | 73.0% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 24 | 24 | $2,712 | $1,025 | 37.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 15 | $1,305 | $630.70 | 48.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 36 | 36 | $2,700 | $411.39 | 15.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 367 | 615 | $110,663 | $61,131 | 55.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 311 | 311 | $38,604 | $37,907 | 98.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 280 | 544 | $66,901 | $37,079 | 55.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 131 | 131 | $19,650 | $11,442 | 58.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 76 | 96 | $14,112 | $8,048 | 57.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 304 | 304 | $9,120 | $6,150 | 67.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 33 | 33 | $5,775 | $5,698 | 98.7% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 26 | 30 | $6,300 | $4,973 | 78.9% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2022 | 42 | 42 | $10,500 | $3,197 | 30.5% |
About Dr. Vanitha Yadalla, MD
Dr. Vanitha Yadalla, MD is a Geriatric Medicine healthcare provider based in Wall Township, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2005. The National Provider Identifier (NPI) number assigned to this provider is 1093702961.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vanitha Yadalla, MD has received a total of $7,233 in payments from pharmaceutical and medical device companies, with $1,493 received in 2024. These payments were reported across 352 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($5,733).
As a Medicare-enrolled provider, Yadalla has provided services to 6,399 Medicare beneficiaries, totaling 8,417 services with total Medicare billing of $687,336. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Geriatric Medicine
- Other Specialties Hypertension Specialist, Internal Medicine
- Location Wall Township, NJ
- Active Since 10/05/2005
- Last Updated 07/17/2025
- Taxonomy Code 207RG0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1093702961
Products in Payments
- NURTEC ODT (Drug) $1,238
- BREZTRI (Drug) $572.06
- AIRSUPRA (Drug) $323.14
- COLOGUARD (Device) $280.56
- FARXIGA (Drug) $260.55
- CHANTIX (Drug) $217.81
- Trintellix (Drug) $196.03
- VRAYLAR (Drug) $194.32
- UBRELVY (Drug) $185.65
- TRELEGY ELLIPTA (Drug) $181.93
- Vascepa (Drug) $169.77
- Ozempic (Drug) $150.00
- LYRICA (Drug) $136.54
- XARELTO (Drug) $130.69
- EUCRISA (Drug) $125.00
- ELIQUIS (Drug) $121.81
- ZAVZPRET (Drug) $119.41
- TOUJEO (Drug) $103.16
- SYMBICORT (Drug) $98.54
- JANUVIA (Drug) $92.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.